Activateur de plasminogène hybride

Patent europeic · EP0277313 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP0277313
Numer da la dumonda
EP87117892
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
03-12-1987
Publitgà
10-08-1988
Concedì
22-01-1997
Stritgà
02-12-2007
Motiv
Durada maximala cuntanschida
Classas IPC
C12N 15/12 (2006.01)
C12N 9/72 (2006.01)
C12N 5/00 (2006.01)
A61K 38/46 (2006.01)
Prioritad
GB 8629153 05.12.1986
GB 8701160 20.01.1987
GB 8709656 23.04.1987
GB 8715890 06.07.1987
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 28-12-2007

    Durada maximala cuntanschida

    Published in +pat+ No 24 in 2007

  2. 14-02-1997

    Adressa midada

    Owner
    CIBA-GEIGY AG, Klybeckstrasse 141, 4002 Basel → Novartis AG, Schwarzwaldallee 215, 4058 Basel

    Published in PIDTJ No 3 in 1997

  3. 31-01-1997

    Concedì

    Published in PIDTJ No 2 in 1997

Partidas

Possessur

Novartis AG

Schwarzwaldallee 215, 4058 Basel

Inventur

Rajput, Bhanu, Dr.

CH-4053 Basel

Chaudhuri, Bhabatosh, Dr.

CH-4058 Basel

Asselbergs, Fredericus Alphonsus Maria, Dr.

CH-4125 Riehen

Meyhack, Bernd, Dr.

CH-4312 Magden

Heim, Jutta, Dr.

CH-4133 Pratteln

van Oostrum, Jan, Dr.

CH-4142 Münchenstein

Alkan, Sefik, Prof. Dr.

CH-4125 Riehen

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.